BIOMERICA INC. - COMMON STOCK
0.6000
02-May-24 15:59:06
15 minutes delayed
Stocks
-0.0301
-4.78%
Today's range
0.5922 - 0.6301
ISIN
N/A
Source
NASDAQ
-
08 Mar 2023 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock
07 Mar 2023 16:39:57 By Nasdaq GlobeNewswire
-
Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock
03 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Biomerica Announces Proposed Underwritten Public Offering of Common Stock
02 Mar 2023 17:15:01 By Nasdaq GlobeNewswire
-
Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022
13 Jan 2023 18:39:00 By Nasdaq GlobeNewswire
-
10 Jan 2023 08:19:00 By Nasdaq GlobeNewswire
-
08 Dec 2022 08:19:00 By Nasdaq GlobeNewswire
-
02 Nov 2022 08:19:00 By Nasdaq GlobeNewswire
-
14 Oct 2022 09:18:00 By Nasdaq GlobeNewswire
-
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13 Oct 2022 16:50:00 By Nasdaq GlobeNewswire
-
29 Sep 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer
30 Aug 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Reports Fiscal 2022 Year End Results
29 Aug 2022 16:41:00 By Nasdaq GlobeNewswire
-
Walmart to Begin Selling Biomerica’s Aware® Breast Self Exam
14 Jul 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica to Participate at BTIG Biotech Conference
23 Jun 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™
12 May 2022 08:19:00 By Nasdaq GlobeNewswire
-
26 Apr 2022 08:19:00 By Nasdaq GlobeNewswire
-
Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021
14 Apr 2022 08:37:00 By Nasdaq GlobeNewswire
-
08 Feb 2022 06:39:00 By Nasdaq GlobeNewswire
-
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
13 Jan 2022 08:19:00 By Nasdaq GlobeNewswire